Related content

Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications

By Rachmani R.   Slavachevski I.   Levi Z.   Zadok B.-S.   Kedar Y.   Ravid M.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 428-433

Elsevier

Access to resources Recommend Favorite

Coffee to Reduce Risk of Type 2 Diabetes? : A Systematic Review

By  

Current Diabetes Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 162-168

Bentham Science Publishers

Access to resources Recommend Favorite

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Johnson J.   Simpson S.   Eurich D.   Majumdar S.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2805-2806

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Tayek J.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2807-2808

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Raccah D.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1109-1110

Springer Publishing Company

Access to resources Recommend Favorite